Sippl, C.; Schoeneberger, L.; Teping, F.; Schulz-Schaeffer, W.; Urbschat, S.; Ketter, R.; Oertel, J.
Impact of MiRNA-181a2 on the Clinical Course of IDH1 Wild Type Glioblastoma. Processes 2021, 9, 728.
https://doi.org/10.3390/pr9050728
AMA Style
Sippl C, Schoeneberger L, Teping F, Schulz-Schaeffer W, Urbschat S, Ketter R, Oertel J.
Impact of MiRNA-181a2 on the Clinical Course of IDH1 Wild Type Glioblastoma. Processes. 2021; 9(5):728.
https://doi.org/10.3390/pr9050728
Chicago/Turabian Style
Sippl, Christoph, Louisa Schoeneberger, Fritz Teping, Walter Schulz-Schaeffer, Steffi Urbschat, Ralf Ketter, and Joachim Oertel.
2021. "Impact of MiRNA-181a2 on the Clinical Course of IDH1 Wild Type Glioblastoma" Processes 9, no. 5: 728.
https://doi.org/10.3390/pr9050728
APA Style
Sippl, C., Schoeneberger, L., Teping, F., Schulz-Schaeffer, W., Urbschat, S., Ketter, R., & Oertel, J.
(2021). Impact of MiRNA-181a2 on the Clinical Course of IDH1 Wild Type Glioblastoma. Processes, 9(5), 728.
https://doi.org/10.3390/pr9050728